Literature DB >> 15275716

Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid.

Carlos Conill1, Alberto Sánchez-Reyes, Meritxell Molla, Antonio Vilalta.   

Abstract

PURPOSE: Some eyelid tumors present a great challenge for surgical therapy because of the cosmetic and functional impairment. Interstitial radiation with (192)Ir is an optimal alternative treatment modality. The aim of this study was to evaluate the local tumor control and cosmetic results in patients with eyelid tumors treated by interstitial (192)Ir wires. METHODS AND MATERIALS: Twenty-four previously untreated carcinomas involving the eyelid tarsal structure in 23 patients were treated with (192)Ir wire implantation. The tumor location was in the lower eyelid in 22 cases and in the upper eyelid in 2. The mean tumor size was 1.33 cm. Of the 24 tumors, 79.2% were basal cell carcinoma, 16.7% were squamous cell carcinoma, and 4.2% were adenocarcinoma. The total radiation dose was 4000 cGy, delivered to 2-mm depth (mean dose rate, 73 cGy/h).
RESULTS: The mean follow-up was 43 months. Local control was obtained in 22 (91.6%) of 24 tumors. Good functional results were achieved in all patients.
CONCLUSION: (192)Ir interstitial brachytherapy in a braided silk filament appears to be an excellent method to treat carcinomas involving the eyelid tarsal structure for tumor control and functional and cosmetic results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15275716     DOI: 10.1016/j.ijrobp.2004.01.048

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Interstitial brachytherapy for eyelid carcinoma. Outcome analysis in 60 patients.

Authors:  M Krengli; L Masini; A M Comoli; E Negri; L Deantonio; A Filomeno; G Gambaro
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

2.  Postoperative interstitial brachytherapy in eyelid cancer: long term results and assessment of Cosmesis After Interstitial Brachytherapy scale.

Authors:  Sarbani Ghosh Laskar; Trinanjan Basu; Suresh Chaudhary; Devendra Chaukar; Mandar Nadkarni; Manjunatha Gn
Journal:  J Contemp Brachytherapy       Date:  2014-11-06

3.  A pilot study of ultrasound-guided electronic brachytherapy for skin cancer.

Authors:  Uma Goyal; Yongbok Kim; Hina Arif Tiwari; Russell Witte; Baldassarre Stea
Journal:  J Contemp Brachytherapy       Date:  2015-10-30

Review 4.  Brachytherapy in non melanoma skin cancer of eyelid: a systematic review.

Authors:  Rezarta Frakulli; Andrea Galuppi; Silvia Cammelli; Gabriella Macchia; Simona Cima; Maria A Gambacorta; Ines Cafaro; Luca Tagliaferri; Elisabetta Perrucci; Milly Buwenge; Giovanni Frezza; Vincenzo Valentini; Alessio G Morganti
Journal:  J Contemp Brachytherapy       Date:  2015-12-16

5.  High-dose-rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report.

Authors:  Yoshiaki Takagawa; Naoya Murakami; Shigenobu Suzuki; Fumihiko Matsumoto; Seiichi Yoshimoto; Jun Itami
Journal:  Clin Case Rep       Date:  2019-08-15

6.  Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand.

Authors:  Daniel W Kim; Ivan M Buzurovic; Brandon V Mahal; William Hwang; Oluwadamilola T Oladeru; Desmond A O'Farrell; Thomas C Harris; Danielle N Margalit; Miranda Lam; Phillip M Devlin
Journal:  J Contemp Brachytherapy       Date:  2020-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.